SUPN Financial Statements

Balance sheet, income statement, cash flow, and dividends for Supernus Pharmaceuticals Inc (SUPN).


$2.00B Market Cap.

As of 02/25/2025 5:00 PM ET (MRY) • Disclaimer

SUPN Market Cap. (MRY)


SUPN Shares Outstanding (MRY)


SUPN Assets (MRY)


Total Assets

$1.37B

Total Liabilities

$332.34M

Total Investments

$384.28M

SUPN Income (MRY)


Revenue

$661.82M

Net Income

$73.86M

Operating Expense

$508.36M

SUPN Cash Flow (MRY)


CF Operations

$171.95M

CF Investing

-$189.87M

CF Financing

$12.19M

SUPN Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

SUPN Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$1,368,073,000 (7.08%)

$1,277,673,000 (-24.95%)

$1,702,508,000 (0.79%)

$1,689,152,000 (12.30%)

Assets Current

$686,070,000 (39.13%)

$493,113,000 (-32.83%)

$734,151,000 (22.04%)

$601,590,000 (-4.57%)

Assets Non-Current

$682,003,000 (-13.07%)

$784,560,000 (-18.98%)

$968,357,000 (-10.96%)

$1,087,562,000 (24.48%)

Goodwill & Intangible Assets

$638,931,000 (-10.88%)

$716,908,000 (-12.52%)

$819,482,000 (-9.17%)

$902,209,000 (104.00%)

Shareholders Equity

$1,035,733,000 (12.39%)

$921,516,000 (3.98%)

$886,204,000 (8.62%)

$815,851,000 (9.53%)

Property Plant & Equipment Net

$11,545,000 (-14.67%)

$13,530,000 (-10.83%)

$15,173,000 (-10.51%)

$16,955,000 (-55.17%)

Cash & Equivalents

$69,331,000 (-7.63%)

$75,054,000 (-19.40%)

$93,120,000 (-54.23%)

$203,434,000 (-29.52%)

Accumulated Other Comprehensive Income

-$189,000 (68.13%)

-$593,000 (81.53%)

-$3,210,000 (-308.58%)

$1,539,000 (-82.85%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$384,281,000 (95.63%)

$196,437,000 (-57.49%)

$462,110,000 (80.93%)

$255,412,000 (-47.26%)

Investments Current

$384,281,000 (113.70%)

$179,820,000 (-51.16%)

$368,214,000 (170.26%)

$136,246,000 (1.76%)

Investments Non-Current

$0 (0%)

$16,617,000 (-82.30%)

$93,896,000 (-21.21%)

$119,166,000 (-65.99%)

Inventory

$54,293,000 (-29.86%)

$77,408,000 (-15.44%)

$91,541,000 (6.49%)

$85,959,000 (77.88%)

Trade & Non-Trade Receivables

$142,077,000 (-1.44%)

$144,155,000 (-12.90%)

$165,497,000 (11.12%)

$148,932,000 (5.72%)

Trade & Non-Trade Payables

$76,352,000 (-4.04%)

$79,569,000 (-17.41%)

$96,342,000 (-18.13%)

$117,683,000 (49.09%)

Accumulated Retained Earnings (Deficit)

$556,426,000 (15.31%)

$482,561,000 (0.27%)

$481,245,000 (26.67%)

$379,922,000 (16.36%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$4,961,000 (-80.13%)

$24,963,000 (-49.88%)

$49,809,000 (-41.64%)

$85,355,000 (142.38%)

Total Debt

$27,382,000 (-17.51%)

$33,196,000 (-92.42%)

$437,966,000 (4.14%)

$420,550,000 (7.74%)

Debt Current

$0 (0%)

$0 (0%)

$401,968,000 (0%)

$0 (0%)

Debt Non-Current

$27,382,000 (-17.51%)

$33,196,000 (-7.78%)

$35,998,000 (-91.44%)

$420,550,000 (7.74%)

Total Liabilities

$332,340,000 (-6.69%)

$356,157,000 (-56.37%)

$816,304,000 (-6.53%)

$873,301,000 (15.02%)

Liabilities Current

$292,397,000 (0.76%)

$290,196,000 (-57.82%)

$687,958,000 (118.14%)

$315,379,000 (28.67%)

Liabilities Non-Current

$39,943,000 (-39.44%)

$65,961,000 (-48.61%)

$128,346,000 (-77.00%)

$557,922,000 (8.52%)

SUPN Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$661,817,000 (8.94%)

$607,521,000 (-8.95%)

$667,238,000 (15.09%)

$579,775,000 (11.41%)

Cost of Revenue

$77,906,000 (-7.01%)

$83,779,000 (-3.95%)

$87,221,000 (16.20%)

$75,061,000 (43.09%)

Selling General & Administrative Expense

$321,582,000 (-4.39%)

$336,361,000 (-10.83%)

$377,221,000 (23.78%)

$304,759,000 (51.87%)

Research & Development Expense

$108,796,000 (18.78%)

$91,593,000 (22.86%)

$74,552,000 (-17.59%)

$90,467,000 (19.10%)

Operating Expenses

$508,355,000 (-4.18%)

$530,528,000 (-0.63%)

$533,893,000 (27.52%)

$418,685,000 (42.29%)

Interest Expense

$0 (0%)

$2,415,000 (-65.84%)

$7,070,000 (-69.82%)

$23,423,000 (-1.39%)

Income Tax Expense

$24,005,000 (1552.10%)

$1,453,000 (4440.63%)

$32,000 (-99.84%)

$19,751,000 (-52.63%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

$73,865,000 (5512.84%)

$1,316,000 (-97.83%)

$60,711,000 (13.64%)

$53,424,000 (-57.92%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

$73,865,000 (5512.84%)

$1,316,000 (-97.83%)

$60,711,000 (13.64%)

$53,424,000 (-57.92%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

$73,865,000 (5512.84%)

$1,316,000 (-97.83%)

$60,711,000 (13.64%)

$53,424,000 (-57.92%)

Weighted Average Shares

$55,100,063 (1.03%)

$54,536,281 (1.62%)

$53,665,143 (1.07%)

$53,099,330 (0.92%)

Weighted Average Shares Diluted

$55,958,537 (0.81%)

$55,506,828 (-10.01%)

$61,679,800 (13.47%)

$54,356,744 (1.24%)

Earning Before Interest & Taxes (EBIT)

$97,870,000 (1787.92%)

$5,184,000 (-92.36%)

$67,813,000 (-29.80%)

$96,598,000 (-49.79%)

Gross Profit

$583,911,000 (11.49%)

$523,742,000 (-9.70%)

$580,017,000 (14.92%)

$504,714,000 (7.86%)

Operating Income

$75,556,000 (1213.41%)

-$6,786,000 (-114.71%)

$46,124,000 (-46.39%)

$86,029,000 (-50.47%)

SUPN Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$189,867,000 (-170.65%)

$268,729,000 (224.03%)

-$216,663,000 (-164.50%)

-$81,913,000 (-136.07%)

Net Cash Flow from Financing

$12,193,000 (103.06%)

-$397,880,000 (-3697.65%)

-$10,477,000 (91.97%)

-$130,420,000 (-3764.51%)

Net Cash Flow from Operations

$171,951,000 (54.79%)

$111,085,000 (-4.91%)

$116,826,000 (-8.10%)

$127,127,000 (-8.14%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$5,723,000 (68.32%)

-$18,066,000 (83.62%)

-$110,314,000 (-29.47%)

-$85,206,000 (-179.44%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

-$298,804,000 (4.70%)

Net Cash Flow - Investment Acquisitions and Disposals

-$189,142,000 (-170.24%)

$269,280,000 (224.52%)

-$216,251,000 (-198.77%)

$218,936,000 (-22.51%)

Capital Expenditure

-$725,000 (-31.58%)

-$551,000 (-33.74%)

-$412,000 (79.85%)

-$2,045,000 (44.58%)

Issuance (Repayment) of Debt Securities

$0 (0%)

-$402,500,000 (0%)

$0 (0%)

-$137,515,000 (-17046.51%)

Issuance (Purchase) of Equity Shares

$14,908,000 (125.54%)

$6,610,000 (-46.79%)

$12,423,000 (75.10%)

$7,095,000 (62.69%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$27,755,000 (3.72%)

$26,759,000 (52.32%)

$17,568,000 (-1.91%)

$17,910,000 (8.15%)

Depreciation Amortization & Accretion

$80,414,000 (-5.24%)

$84,859,000 (-0.80%)

$85,543,000 (162.44%)

$32,595,000 (79.68%)

SUPN Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

88.20% (2.32%)

86.20% (-0.81%)

86.90% (-0.23%)

87.10% (-3.11%)

Profit Margin

11.20% (5500.00%)

0.20% (-97.80%)

9.10% (-1.09%)

9.20% (-62.30%)

EBITDA Margin

26.90% (81.76%)

14.80% (-35.65%)

23.00% (3.14%)

22.30% (-44.94%)

Return on Average Equity (ROAE)

7.50% (7400.00%)

0.10% (-98.59%)

7.10% (5.97%)

6.70% (-63.98%)

Return on Average Assets (ROAA)

5.50% (5400.00%)

0.10% (-97.22%)

3.60% (5.88%)

3.40% (-61.80%)

Return on Sales (ROS)

14.80% (1544.44%)

0.90% (-91.18%)

10.20% (-38.92%)

16.70% (-54.86%)

Return on Invested Capital (ROIC)

28.80% (1271.43%)

2.10% (-83.33%)

12.60% (23.53%)

10.20% (-47.96%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

26.98 (-98.14%)

1,447 (4484.05%)

31.57 (9.33%)

28.87 (176.54%)

Price to Sales Ratio (P/S)

3.01 (15.90%)

2.6 (-9.45%)

2.87 (7.41%)

2.67 (4.99%)

Price to Book Ratio (P/B)

1.93 (12.35%)

1.72 (-21.14%)

2.18 (14.47%)

1.9 (6.80%)

Debt to Equity Ratio (D/E)

0.32 (-16.84%)

0.39 (-58.09%)

0.92 (-13.93%)

1.07 (5.00%)

Earnings Per Share (EPS)

1.34 (6600.00%)

0.02 (-98.23%)

1.13 (11.88%)

1.01 (-58.09%)

Sales Per Share (SPS)

12.01 (7.82%)

11.14 (-10.40%)

12.43 (13.87%)

10.92 (10.39%)

Free Cash Flow Per Share (FCFPS)

3.11 (53.33%)

2.03 (-6.55%)

2.17 (-7.94%)

2.36 (-7.97%)

Book Value Per Share (BVPS)

18.8 (11.24%)

16.9 (2.32%)

16.51 (7.48%)

15.37 (8.53%)

Tangible Assets Book Value Per Share (TABVPS)

13.23 (28.70%)

10.28 (-37.51%)

16.45 (11.03%)

14.82 (-26.56%)

Enterprise Value Over EBIT (EV/EBIT)

20 (-93.17%)

293 (787.88%)

33 (83.33%)

18 (125.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

11.18 (-33.74%)

16.88 (14.84%)

14.7 (8.67%)

13.53 (85.54%)

Asset Turnover

0.5 (15.58%)

0.43 (8.31%)

0.4 (8.17%)

0.37 (0.27%)

Current Ratio

2.35 (38.08%)

1.7 (59.23%)

1.07 (-44.08%)

1.91 (-25.82%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

$171,226,000 (54.91%)

$110,534,000 (-5.05%)

$116,414,000 (-6.93%)

$125,082,000 (-7.15%)

Enterprise Value (EV)

$1,993,981,912 (31.19%)

$1,519,930,592 (-32.57%)

$2,254,227,782 (29.00%)

$1,747,519,195 (13.85%)

Earnings Before Tax (EBT)

$97,870,000 (3434.49%)

$2,769,000 (-95.44%)

$60,743,000 (-16.99%)

$73,175,000 (-56.61%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$178,284,000 (98.00%)

$90,043,000 (-41.28%)

$153,356,000 (18.70%)

$129,193,000 (-38.64%)

Invested Capital

$394,796,000 (72.62%)

$228,711,000 (-57.64%)

$539,914,000 (-21.60%)

$688,680,000 (-25.02%)

Working Capital

$393,673,000 (94.01%)

$202,917,000 (339.28%)

$46,193,000 (-83.86%)

$286,211,000 (-25.72%)

Tangible Asset Value

$729,142,000 (30.03%)

$560,765,000 (-36.50%)

$883,026,000 (12.21%)

$786,943,000 (-25.89%)

Market Capitalization

$1,996,728,912 (26.29%)

$1,581,074,592 (-18.00%)

$1,928,253,782 (24.34%)

$1,550,751,195 (16.99%)

Average Equity

$982,375,750 (7.19%)

$916,441,250 (7.54%)

$852,220,500 (7.66%)

$791,585,500 (15.85%)

Average Assets

$1,332,673,250 (-5.61%)

$1,411,935,000 (-16.08%)

$1,682,531,750 (6.41%)

$1,581,173,750 (11.06%)

Invested Capital Average

$339,285,000 (36.60%)

$248,380,000 (-53.96%)

$539,529,750 (-43.09%)

$947,971,000 (-3.34%)

Shares

55,219,273 (1.07%)

54,632,847 (1.06%)

54,058,138 (1.65%)

53,180,768 (0.94%)